Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
AUTOR(ES)
Mills, Gordon B.
FONTE
The National Academy of Sciences
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=56908Documentos Relacionados
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
- Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast
- The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
- Long non-coding RNA HOTAIR induces the PI3K/AKT/mTOR signaling pathway in breast cancer cells
- Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress
